At Novartis, virtual reality is used to understand complex interactions between molecules. It’s a way to facilitate communication between chemist and biologist about drug design and protein’s interactions.
Viktor Hornak, an investigator in the Global Discovery Chemistry department at the Novartis Institutes for BioMedical Research (NIBR), is driving an effort to adapt VR tools for use in the drug design process. He and his colleagues recognize a potential for VR to help drug hunters more quickly improve the molecular makeup of a new drug by smoothing communications between scientists and enabling them to see biological machinery more clearly.
Source: Bringing virtual reality to the lab | Novartis
Bringing the virtual reality to the lab would be a great idea as after the augmented reality people are now taking great advantage of it.